EP Patent

EP0365480A1 — Dispersible formulation

Assigned to Novartis AG · Expires 1990-04-25 · 36y expired

What this patent protects

The invention provides a dispersible solid drug formulation comprising finely divided diclofenac as the free acid, from 5 to 25 % by weight of a disintegrant and a pharmaceutically acceptable diluent.

USPTO Abstract

The invention provides a dispersible solid drug formulation comprising finely divided diclofenac as the free acid, from 5 to 25 % by weight of a disintegrant and a pharmaceutically acceptable diluent.

Drugs covered by this patent

diclofenac-potassium (DICLOFENAC POTASSIUM)

Patent Metadata

Patent number: EP0365480A1
Jurisdiction: EP
Classification: —
Expires: 1990-04-25
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.